Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma.

Geller MA, Ivy J, Dusenbery KE, Ghebre R, Isaksson Vogel R, Argenta PA.

Gynecol Oncol. 2010 Jul;118(1):19-23. doi: 10.1016/j.ygyno.2009.11.025. Epub 2010 Apr 8.

PMID:
20381136
2.

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.

Gynecol Oncol. 2007 Nov;107(2):285-91. Epub 2007 Aug 6.

PMID:
17688923
3.

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.

Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.

Gynecol Oncol. 2009 Sep;114(3):442-7. doi: 10.1016/j.ygyno.2009.06.005. Epub 2009 Jun 26.

PMID:
19560193
4.

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.

Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.

Gynecol Oncol. 2005 Jan;96(1):198-203.

PMID:
15589601
5.

Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.

Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS.

Gynecol Oncol. 2009 Jul;114(1):94-8. doi: 10.1016/j.ygyno.2009.03.027. Epub 2009 Apr 29.

PMID:
19406459
6.

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA.

Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28.

PMID:
19041126
7.

Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.

Lan C, Huang X, Cao X, Huang H, Feng Y, Huang Y, Liu J.

Expert Opin Pharmacother. 2013 Apr;14(5):535-42. doi: 10.1517/14656566.2013.778243.

PMID:
23480059
8.

Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.

Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, Nascu P, Wong E, Carey MS.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):110-6. Epub 2006 Nov 2.

PMID:
17084542
9.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
10.

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study.

Sovak MA, Hensley ML, Dupont J, Ishill N, Alektiar KM, Abu-Rustum N, Barakat R, Chi DS, Sabbatini P, Spriggs DR, Aghajanian C.

Gynecol Oncol. 2006 Nov;103(2):451-7. Epub 2006 May 3.

PMID:
16677690
11.

Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.

Mundt AJ, McBride R, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1145-53.

PMID:
11483323
12.

The long-term survival of women with surgical stage II endometrioid type endometrial cancer.

Ayhan A, Taskiran C, Celik C, Yuce K.

Gynecol Oncol. 2004 Apr;93(1):9-13.

PMID:
15047207
13.

Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

Mehta N, Yamada SD, Rotmensch J, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1004-9.

PMID:
14575831
14.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
15.

Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.

Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS.

Gynecol Oncol. 2009 Mar;112(3):553-7. doi: 10.1016/j.ygyno.2008.11.026. Epub 2009 Jan 9.

PMID:
19135232
16.

Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.

Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K.

Gynecol Oncol. 2004 Aug;94(2):333-9.

PMID:
15297170
17.

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.

Geller MA, Ivy JJ, Ghebre R, Downs LS Jr, Judson PL, Carson LF, Jonson AL, Dusenbery K, Vogel RI, Boente MP, Argenta PA.

Gynecol Oncol. 2011 Apr;121(1):112-7. doi: 10.1016/j.ygyno.2010.12.338. Epub 2011 Jan 15.

PMID:
21239048
18.

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel.

Vaidya AP, Littell R, Krasner C, Duska LR.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:267-72.

PMID:
16515602
19.

Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.

Lu SM, Chang-Halpenny C, Hwang-Graziano J.

Gynecol Oncol. 2015 Apr;137(1):28-33. doi: 10.1016/j.ygyno.2015.01.546. Epub 2015 Feb 7.

PMID:
25666606
20.

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.

Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F.

Gynecol Oncol. 2004 May;93(2):345-52.

PMID:
15099944

Supplemental Content

Support Center